Mount Sinai claims CVS stole $121M in federal prescription cash for poor New Yorkers: fraud suit
Mount Sinai has filed a lawsuit against CVS, alleging that the pharmacy chain stole $121 million from federal funds intended for low-income patients. The lawsuit claims CVS implemented a secret pricing scheme to divert money from the federal 340B drug discount program. Mount Sinai argues that this fraudulent activity has harmed its ability to provide care to uninsured and under-insured individuals in New York City.
- ▪Mount Sinai accuses CVS of orchestrating a $121 million racketeering scheme.
- ▪The lawsuit claims CVS used a secret pricing scheme to manipulate reimbursement rates.
- ▪CVS allegedly refused to provide audit data as required by their contract with Mount Sinai.
New York Post files mainly under news. We currently carry 11,030 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | New York Post |
| Canonical URL | https://nypost.com/2026/05/21/us-news/mount-sinai-claims-cvs-stole-121m-in-federal-prescription-cash-fraud-suit/ |
| Publication time | Thu, 21 May 2026 16:48:32 -0400 |
| Retrieval time | 2026-05-21T20:51:35.709Z |
| Last seen | 2026-05-21T20:51:35.709Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | UcYz0Z9kNjZ8 |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Metro Mount Sinai claims CVS stole $121M in federal prescription cash for poor New Yorkers: fraud suit By Peter Senzamici Published May 21, 2026, 4:48 p.m. ET See more of our coverage in your search results. Add The New York Post on Google Mount Sinai is suing pharmacy giant CVS, accusing it of a $121 million racketeering scheme that siphoned federal prescription drug cash meant for the city’s poorest patients. The sprawling hospital system claims CVS orchestrated a “secret pricing scheme” to pocket massive savings afforded by the federal 340B drug discount program, according to a lawsuit in Manhattan federal court. The alleged fraud scheme deprived Mount Sinai of crucial funds meant for vulnerable, uninsured New Yorkers, claims the suit, filed Monday.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at New York Post.
Discussion
0 commentsMore from New York Post
